Kendra Young
Concepts (305)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lupus Erythematosus, Systemic | 10 | 2022 | 236 | 2.670 |
Why?
| Pulmonary Disease, Chronic Obstructive | 23 | 2024 | 1347 | 2.240 |
Why?
| Tobacco Use Disorder | 4 | 2022 | 251 | 1.080 |
Why?
| Smoking | 13 | 2023 | 1635 | 1.020 |
Why?
| Mexican Americans | 2 | 2019 | 102 | 0.980 |
Why?
| Receptors, Complement 3d | 10 | 2010 | 130 | 0.980 |
Why?
| Autoantibodies | 8 | 2022 | 1382 | 0.950 |
Why?
| Bronchiectasis | 5 | 2023 | 112 | 0.920 |
Why?
| Vitamin D | 5 | 2022 | 362 | 0.920 |
Why?
| Genetic Predisposition to Disease | 13 | 2023 | 2382 | 0.910 |
Why?
| Smokers | 9 | 2023 | 180 | 0.900 |
Why?
| Non-alcoholic Fatty Liver Disease | 3 | 2023 | 286 | 0.820 |
Why?
| Herpesvirus 4, Human | 4 | 2019 | 129 | 0.800 |
Why?
| Diabetes Mellitus, Type 2 | 6 | 2023 | 2236 | 0.790 |
Why?
| Vitamin D Deficiency | 2 | 2016 | 167 | 0.780 |
Why?
| Genome-Wide Association Study | 14 | 2023 | 1403 | 0.730 |
Why?
| Blood Pressure Monitoring, Ambulatory | 1 | 2020 | 68 | 0.700 |
Why?
| Alanine Transaminase | 2 | 2020 | 153 | 0.670 |
Why?
| Family | 2 | 2014 | 640 | 0.670 |
Why?
| Aspartate Aminotransferases | 1 | 2019 | 97 | 0.650 |
Why?
| Lipase | 1 | 2019 | 81 | 0.640 |
Why?
| Inflammation Mediators | 2 | 2019 | 515 | 0.630 |
Why?
| Virus Attachment | 2 | 2008 | 11 | 0.620 |
Why?
| Polymorphism, Single Nucleotide | 11 | 2023 | 2135 | 0.600 |
Why?
| Smoking Cessation | 1 | 2022 | 398 | 0.600 |
Why?
| Cholesterol, HDL | 1 | 2018 | 217 | 0.590 |
Why?
| Vitamin D3 24-Hydroxylase | 1 | 2016 | 15 | 0.540 |
Why?
| Membrane Proteins | 2 | 2020 | 1089 | 0.540 |
Why?
| Triglycerides | 1 | 2018 | 551 | 0.530 |
Why?
| Arthritis, Rheumatoid | 4 | 2022 | 1001 | 0.520 |
Why?
| Tomography, X-Ray Computed | 11 | 2023 | 2539 | 0.520 |
Why?
| Coronary Artery Disease | 3 | 2023 | 721 | 0.510 |
Why?
| Adiposity | 2 | 2012 | 529 | 0.510 |
Why?
| Insulin-Secreting Cells | 1 | 2018 | 334 | 0.470 |
Why?
| Forced Expiratory Volume | 11 | 2024 | 588 | 0.470 |
Why?
| Metabolic Syndrome | 1 | 2018 | 399 | 0.470 |
Why?
| Middle Aged | 28 | 2023 | 29112 | 0.470 |
Why?
| Atherosclerosis | 3 | 2023 | 360 | 0.460 |
Why?
| Humans | 68 | 2024 | 125131 | 0.450 |
Why?
| Pulmonary Emphysema | 3 | 2023 | 362 | 0.440 |
Why?
| Insulin Resistance | 2 | 2018 | 1214 | 0.430 |
Why?
| Spirometry | 9 | 2024 | 314 | 0.420 |
Why?
| Joints | 1 | 2013 | 87 | 0.420 |
Why?
| Viral Matrix Proteins | 4 | 2008 | 24 | 0.420 |
Why?
| Sleep | 1 | 2018 | 763 | 0.400 |
Why?
| Male | 32 | 2023 | 60792 | 0.390 |
Why?
| Hypertension | 1 | 2020 | 1257 | 0.390 |
Why?
| Female | 34 | 2023 | 64889 | 0.380 |
Why?
| Complement C3d | 7 | 2010 | 60 | 0.380 |
Why?
| Emphysema | 2 | 2023 | 131 | 0.360 |
Why?
| Risk Factors | 18 | 2023 | 9549 | 0.360 |
Why?
| Autoimmunity | 3 | 2022 | 835 | 0.350 |
Why?
| Genetic Loci | 4 | 2022 | 299 | 0.350 |
Why?
| Adult | 17 | 2023 | 33167 | 0.330 |
Why?
| Follow-Up Studies | 8 | 2022 | 4824 | 0.330 |
Why?
| Diabetic Angiopathies | 1 | 2010 | 276 | 0.310 |
Why?
| Calcinosis | 1 | 2010 | 304 | 0.290 |
Why?
| Viral Envelope Proteins | 1 | 2007 | 82 | 0.280 |
Why?
| HLA-DR4 Antigen | 1 | 2007 | 76 | 0.280 |
Why?
| Prospective Studies | 9 | 2023 | 6818 | 0.260 |
Why?
| Rheumatoid Factor | 1 | 2007 | 156 | 0.260 |
Why?
| Glycoproteins | 1 | 2007 | 330 | 0.260 |
Why?
| Tobacco Use | 2 | 2023 | 64 | 0.250 |
Why?
| Population Surveillance | 2 | 2021 | 444 | 0.250 |
Why?
| Genotype | 6 | 2022 | 1960 | 0.240 |
Why?
| Alcohol Drinking | 2 | 2022 | 710 | 0.240 |
Why?
| Genetic Markers | 2 | 2019 | 368 | 0.240 |
Why?
| Multifactorial Inheritance | 2 | 2023 | 145 | 0.240 |
Why?
| Artificial Intelligence | 2 | 2023 | 158 | 0.240 |
Why?
| Acyltransferases | 2 | 2023 | 54 | 0.230 |
Why?
| Cohort Studies | 7 | 2023 | 5348 | 0.230 |
Why?
| Vitamin D-Binding Protein | 2 | 2016 | 15 | 0.230 |
Why?
| Liver | 3 | 2023 | 1872 | 0.220 |
Why?
| Receptors, Calcitriol | 2 | 2016 | 58 | 0.220 |
Why?
| Autoimmune Diseases | 1 | 2007 | 406 | 0.220 |
Why?
| Plaque, Atherosclerotic | 1 | 2023 | 47 | 0.220 |
Why?
| Drug Repositioning | 1 | 2023 | 18 | 0.210 |
Why?
| Tomography, Emission-Computed | 1 | 2022 | 57 | 0.210 |
Why?
| Aged | 13 | 2022 | 20859 | 0.210 |
Why?
| Peptides, Cyclic | 2 | 2015 | 265 | 0.210 |
Why?
| Risk Assessment | 5 | 2019 | 3274 | 0.210 |
Why?
| Population Health | 1 | 2023 | 48 | 0.210 |
Why?
| Phenotype | 7 | 2022 | 3153 | 0.210 |
Why?
| Liver Cirrhosis | 2 | 2023 | 249 | 0.210 |
Why?
| Hyperlipidemias | 1 | 2023 | 144 | 0.200 |
Why?
| Internationality | 1 | 2022 | 162 | 0.200 |
Why?
| Longitudinal Studies | 5 | 2023 | 2669 | 0.200 |
Why?
| Symptom Flare Up | 1 | 2021 | 39 | 0.190 |
Why?
| Airway Obstruction | 1 | 2024 | 187 | 0.190 |
Why?
| Disease Progression | 4 | 2023 | 2577 | 0.190 |
Why?
| Lung | 9 | 2023 | 3865 | 0.180 |
Why?
| Amino Acid Substitution | 4 | 2010 | 279 | 0.180 |
Why?
| Transcriptome | 2 | 2023 | 801 | 0.180 |
Why?
| Muscular Atrophy | 1 | 2021 | 86 | 0.180 |
Why?
| Mutagenesis, Site-Directed | 4 | 2010 | 369 | 0.180 |
Why?
| Respiratory Function Tests | 2 | 2019 | 581 | 0.180 |
Why?
| Prevalence | 6 | 2023 | 2488 | 0.170 |
Why?
| China | 1 | 2020 | 225 | 0.170 |
Why?
| Alleles | 3 | 2019 | 865 | 0.170 |
Why?
| Diabetes Mellitus, Type 1 | 2 | 2020 | 3471 | 0.170 |
Why?
| Genetic Variation | 2 | 2022 | 970 | 0.170 |
Why?
| Linear Models | 2 | 2019 | 870 | 0.170 |
Why?
| Pulmonary Heart Disease | 1 | 2019 | 7 | 0.170 |
Why?
| Blood Pressure Determination | 1 | 2020 | 139 | 0.170 |
Why?
| Quantitative Trait, Heritable | 1 | 2020 | 125 | 0.170 |
Why?
| Molecular Epidemiology | 1 | 2019 | 74 | 0.170 |
Why?
| gamma-Glutamyltransferase | 1 | 2019 | 47 | 0.170 |
Why?
| Nuclear Family | 1 | 2019 | 54 | 0.160 |
Why?
| Binding Sites | 5 | 2010 | 1248 | 0.160 |
Why?
| Protein Binding | 7 | 2010 | 2014 | 0.160 |
Why?
| Antigens, Viral | 1 | 2019 | 182 | 0.160 |
Why?
| Hepatitis C | 2 | 2011 | 239 | 0.160 |
Why?
| Heart Ventricles | 2 | 2020 | 763 | 0.150 |
Why?
| Vascular Remodeling | 1 | 2019 | 160 | 0.150 |
Why?
| Herpesviridae Infections | 1 | 2019 | 147 | 0.150 |
Why?
| Vital Capacity | 3 | 2023 | 290 | 0.150 |
Why?
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2017 | 29 | 0.150 |
Why?
| Blood Pressure | 2 | 2023 | 1735 | 0.140 |
Why?
| United States | 5 | 2020 | 13613 | 0.140 |
Why?
| Pulmonary Artery | 2 | 2022 | 1110 | 0.140 |
Why?
| Severity of Illness Index | 3 | 2021 | 2848 | 0.140 |
Why?
| Case-Control Studies | 4 | 2019 | 3326 | 0.140 |
Why?
| Prognosis | 3 | 2021 | 3616 | 0.140 |
Why?
| Lipids | 1 | 2020 | 629 | 0.140 |
Why?
| Lung Diseases | 1 | 2023 | 768 | 0.140 |
Why?
| Protein Structure, Tertiary | 3 | 2008 | 836 | 0.140 |
Why?
| Coronary Vessels | 1 | 2018 | 256 | 0.140 |
Why?
| 25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 1 | 2016 | 17 | 0.140 |
Why?
| Crystallography, X-Ray | 6 | 2010 | 432 | 0.140 |
Why?
| Fatigue | 1 | 2018 | 324 | 0.130 |
Why?
| Complement C3b | 3 | 2007 | 30 | 0.130 |
Why?
| Body Mass Index | 3 | 2021 | 2174 | 0.130 |
Why?
| Mutation, Missense | 2 | 2008 | 305 | 0.130 |
Why?
| Machine Learning | 1 | 2019 | 353 | 0.130 |
Why?
| Medical Staff, Hospital | 1 | 2016 | 84 | 0.130 |
Why?
| Antibodies, Viral | 1 | 2019 | 561 | 0.130 |
Why?
| Fatty Acids, Omega-3 | 1 | 2015 | 125 | 0.120 |
Why?
| Abdominal Fat | 2 | 2017 | 48 | 0.120 |
Why?
| Gene Frequency | 3 | 2022 | 528 | 0.120 |
Why?
| Antibodies, Antinuclear | 1 | 2014 | 58 | 0.110 |
Why?
| Multivariate Analysis | 3 | 2019 | 1561 | 0.110 |
Why?
| Enzyme-Linked Immunosorbent Assay | 4 | 2019 | 837 | 0.110 |
Why?
| Europe | 3 | 2022 | 369 | 0.110 |
Why?
| Fluorescent Antibody Technique | 1 | 2014 | 415 | 0.110 |
Why?
| Hyperglycemia | 1 | 2016 | 335 | 0.100 |
Why?
| Calcium | 1 | 2018 | 1211 | 0.100 |
Why?
| Models, Molecular | 6 | 2008 | 1450 | 0.100 |
Why?
| Cross-Sectional Studies | 4 | 2024 | 4854 | 0.100 |
Why?
| Family Health | 1 | 2013 | 209 | 0.100 |
Why?
| Recombinant Proteins | 5 | 2007 | 1327 | 0.100 |
Why?
| Sample Size | 2 | 2022 | 138 | 0.100 |
Why?
| Dyspnea | 2 | 2024 | 220 | 0.100 |
Why?
| Peptide Fragments | 3 | 2007 | 713 | 0.100 |
Why?
| Mutant Proteins | 2 | 2010 | 102 | 0.100 |
Why?
| Patient Care Team | 1 | 2016 | 546 | 0.100 |
Why?
| Antibodies, Monoclonal | 4 | 2007 | 1300 | 0.100 |
Why?
| Proportional Hazards Models | 3 | 2019 | 1191 | 0.100 |
Why?
| Cardiovascular Diseases | 1 | 2023 | 1904 | 0.090 |
Why?
| Texas | 1 | 2012 | 202 | 0.090 |
Why?
| Hypertension, Pulmonary | 1 | 2022 | 1880 | 0.090 |
Why?
| Protein Interaction Mapping | 2 | 2008 | 107 | 0.090 |
Why?
| Registries | 1 | 2019 | 2050 | 0.090 |
Why?
| Predictive Value of Tests | 2 | 2018 | 1992 | 0.090 |
Why?
| Chi-Square Distribution | 1 | 2012 | 558 | 0.090 |
Why?
| K562 Cells | 2 | 2007 | 76 | 0.090 |
Why?
| Epidemics | 1 | 2011 | 76 | 0.090 |
Why?
| Quality of Life | 1 | 2021 | 2580 | 0.080 |
Why?
| Depression | 1 | 2018 | 1236 | 0.080 |
Why?
| Life Style | 1 | 2012 | 442 | 0.080 |
Why?
| Retrospective Studies | 3 | 2021 | 13708 | 0.080 |
Why?
| Intra-Abdominal Fat | 1 | 2009 | 102 | 0.080 |
Why?
| Sex Factors | 2 | 2020 | 1901 | 0.080 |
Why?
| Exercise Tolerance | 2 | 2020 | 245 | 0.080 |
Why?
| Protein Interaction Domains and Motifs | 1 | 2008 | 139 | 0.070 |
Why?
| Meta-Analysis as Topic | 2 | 2020 | 173 | 0.070 |
Why?
| Point Mutation | 1 | 2008 | 236 | 0.070 |
Why?
| Regression Analysis | 2 | 2022 | 1047 | 0.070 |
Why?
| Insulin | 1 | 2017 | 2219 | 0.070 |
Why?
| Polymorphism, Genetic | 1 | 2010 | 669 | 0.070 |
Why?
| Hospitalization | 1 | 2016 | 1960 | 0.070 |
Why?
| Surveys and Questionnaires | 2 | 2022 | 5061 | 0.070 |
Why?
| Bottle Feeding | 1 | 2007 | 22 | 0.070 |
Why?
| Histocompatibility Testing | 1 | 2007 | 125 | 0.070 |
Why?
| Bronchodilator Agents | 2 | 2021 | 262 | 0.070 |
Why?
| Health Behavior | 1 | 2012 | 758 | 0.070 |
Why?
| Interferon-alpha | 1 | 2006 | 193 | 0.060 |
Why?
| Tobacco Smoke Pollution | 1 | 2007 | 244 | 0.060 |
Why?
| Phospholipases | 1 | 2023 | 14 | 0.060 |
Why?
| Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 1 | 2023 | 24 | 0.060 |
Why?
| Carotid Intima-Media Thickness | 1 | 2023 | 69 | 0.060 |
Why?
| Multimorbidity | 1 | 2023 | 33 | 0.050 |
Why?
| Biomarkers | 1 | 2013 | 3736 | 0.050 |
Why?
| Pandemics | 1 | 2011 | 1434 | 0.050 |
Why?
| B-Lymphocytes | 1 | 2007 | 781 | 0.050 |
Why?
| Aged, 80 and over | 3 | 2019 | 6936 | 0.050 |
Why?
| Nutrition Surveys | 1 | 2024 | 249 | 0.050 |
Why?
| Whole Genome Sequencing | 1 | 2022 | 117 | 0.050 |
Why?
| Pectoralis Muscles | 1 | 2021 | 21 | 0.050 |
Why?
| Biology | 1 | 2023 | 85 | 0.050 |
Why?
| Colorado | 1 | 2012 | 4471 | 0.050 |
Why?
| Epitope Mapping | 1 | 2001 | 51 | 0.050 |
Why?
| Reference Values | 1 | 2023 | 818 | 0.050 |
Why?
| Logistic Models | 1 | 2007 | 2040 | 0.050 |
Why?
| Cell Line, Tumor | 1 | 2008 | 2913 | 0.050 |
Why?
| Bronchi | 1 | 2022 | 259 | 0.050 |
Why?
| Ligands | 4 | 2006 | 574 | 0.050 |
Why?
| Vitamins | 1 | 2022 | 163 | 0.050 |
Why?
| Adrenergic beta-2 Receptor Agonists | 1 | 2021 | 36 | 0.050 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 2023 | 410 | 0.050 |
Why?
| Inheritance Patterns | 1 | 2020 | 50 | 0.050 |
Why?
| Molecular Sequence Annotation | 1 | 2020 | 94 | 0.040 |
Why?
| Interleukin-10 | 1 | 2022 | 311 | 0.040 |
Why?
| Linkage Disequilibrium | 1 | 2020 | 288 | 0.040 |
Why?
| rab4 GTP-Binding Proteins | 1 | 2019 | 9 | 0.040 |
Why?
| Transforming Growth Factor beta | 1 | 2022 | 457 | 0.040 |
Why?
| Cytochrome P-450 CYP2B6 | 1 | 2019 | 10 | 0.040 |
Why?
| Cytochrome P450 Family 2 | 1 | 2019 | 13 | 0.040 |
Why?
| Hepacivirus | 2 | 2011 | 240 | 0.040 |
Why?
| Age Factors | 1 | 2007 | 3152 | 0.040 |
Why?
| Drug Discovery | 1 | 2020 | 129 | 0.040 |
Why?
| Walk Test | 1 | 2019 | 61 | 0.040 |
Why?
| Surface Plasmon Resonance | 3 | 2006 | 84 | 0.040 |
Why?
| Administration, Inhalation | 1 | 2021 | 667 | 0.040 |
Why?
| Aryl Hydrocarbon Hydroxylases | 1 | 2019 | 45 | 0.040 |
Why?
| Binding, Competitive | 3 | 2006 | 209 | 0.040 |
Why?
| Genomics | 1 | 2023 | 726 | 0.040 |
Why?
| Organ Size | 1 | 2019 | 479 | 0.040 |
Why?
| Organ Specificity | 1 | 2019 | 288 | 0.040 |
Why?
| Cluster Analysis | 1 | 2019 | 497 | 0.040 |
Why?
| Self Report | 1 | 2022 | 750 | 0.040 |
Why?
| Drug Therapy, Combination | 1 | 2021 | 1006 | 0.040 |
Why?
| Factor Analysis, Statistical | 1 | 2018 | 286 | 0.040 |
Why?
| Body Composition | 1 | 2021 | 679 | 0.040 |
Why?
| Tobacco Products | 1 | 2019 | 122 | 0.040 |
Why?
| Adrenal Cortex Hormones | 1 | 2021 | 524 | 0.040 |
Why?
| Mortality | 1 | 2019 | 327 | 0.040 |
Why?
| Chronic Disease | 1 | 2023 | 1684 | 0.040 |
Why?
| Environment | 1 | 2019 | 355 | 0.040 |
Why?
| Diagnostic Imaging | 1 | 2019 | 311 | 0.040 |
Why?
| Incidence | 2 | 2015 | 2578 | 0.030 |
Why?
| Cause of Death | 1 | 2018 | 394 | 0.030 |
Why?
| Kaplan-Meier Estimate | 1 | 2018 | 879 | 0.030 |
Why?
| Glucose Tolerance Test | 1 | 2017 | 373 | 0.030 |
Why?
| Chromosomes, Human, Pair 4 | 1 | 2015 | 35 | 0.030 |
Why?
| Risk | 1 | 2019 | 896 | 0.030 |
Why?
| Chromosomes, Human, Pair 15 | 1 | 2015 | 70 | 0.030 |
Why?
| Quantitative Trait Loci | 1 | 2017 | 349 | 0.030 |
Why?
| Amino Acid Sequence | 3 | 2006 | 2098 | 0.030 |
Why?
| Receptors, IgE | 2 | 2006 | 40 | 0.030 |
Why?
| Molecular Sequence Data | 3 | 2006 | 2926 | 0.030 |
Why?
| Mutagenesis | 2 | 2006 | 183 | 0.030 |
Why?
| Repetitive Sequences, Amino Acid | 2 | 2005 | 16 | 0.030 |
Why?
| Genome, Human | 1 | 2015 | 396 | 0.030 |
Why?
| Child, Preschool | 1 | 2007 | 9938 | 0.030 |
Why?
| Solutions | 2 | 2005 | 156 | 0.030 |
Why?
| Egypt | 1 | 2011 | 11 | 0.020 |
Why?
| Israel | 1 | 2011 | 39 | 0.020 |
Why?
| Inflammation | 1 | 2022 | 2612 | 0.020 |
Why?
| Asia | 1 | 2011 | 57 | 0.020 |
Why?
| Consensus Sequence | 2 | 2001 | 71 | 0.020 |
Why?
| Protein Conformation | 2 | 2006 | 861 | 0.020 |
Why?
| Australia | 1 | 2011 | 228 | 0.020 |
Why?
| Time Factors | 2 | 2011 | 6780 | 0.020 |
Why?
| Canada | 1 | 2011 | 359 | 0.020 |
Why?
| Molecular Dynamics Simulation | 1 | 2010 | 217 | 0.020 |
Why?
| Infant | 1 | 2021 | 8625 | 0.020 |
Why?
| Child | 1 | 2007 | 20014 | 0.020 |
Why?
| Spodoptera | 1 | 2006 | 39 | 0.020 |
Why?
| Myxovirus Resistance Proteins | 1 | 2006 | 8 | 0.020 |
Why?
| Dose-Response Relationship, Immunologic | 1 | 2006 | 83 | 0.020 |
Why?
| HSP40 Heat-Shock Proteins | 1 | 2006 | 22 | 0.020 |
Why?
| Glycosylation | 1 | 2006 | 133 | 0.020 |
Why?
| Polysaccharides | 1 | 2006 | 88 | 0.020 |
Why?
| GTP-Binding Proteins | 1 | 2006 | 159 | 0.020 |
Why?
| Sodium Chloride | 1 | 2006 | 154 | 0.020 |
Why?
| Hydrogen-Ion Concentration | 1 | 2006 | 562 | 0.020 |
Why?
| Protein Structure, Quaternary | 1 | 2005 | 116 | 0.020 |
Why?
| Static Electricity | 1 | 2005 | 122 | 0.010 |
Why?
| Dimerization | 1 | 2005 | 181 | 0.010 |
Why?
| Animals | 4 | 2010 | 34345 | 0.010 |
Why?
| Membrane Glycoproteins | 1 | 2006 | 454 | 0.010 |
Why?
| Multiprotein Complexes | 1 | 2005 | 151 | 0.010 |
Why?
| Neutrons | 1 | 2002 | 5 | 0.010 |
Why?
| In Vitro Techniques | 1 | 2005 | 1144 | 0.010 |
Why?
| Scattering, Radiation | 1 | 2002 | 94 | 0.010 |
Why?
| Antigen-Antibody Complex | 1 | 2001 | 90 | 0.010 |
Why?
| Protein Sorting Signals | 1 | 2001 | 16 | 0.010 |
Why?
| Pichia | 1 | 2001 | 20 | 0.010 |
Why?
| Ultracentrifugation | 1 | 2001 | 50 | 0.010 |
Why?
| Hydrogen Bonding | 1 | 2001 | 150 | 0.010 |
Why?
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2001 | 139 | 0.010 |
Why?
| Cell Line | 1 | 2006 | 2806 | 0.010 |
Why?
| Sequence Alignment | 1 | 2001 | 338 | 0.010 |
Why?
| Protein Structure, Secondary | 1 | 2001 | 341 | 0.010 |
Why?
| Cloning, Molecular | 1 | 2001 | 566 | 0.010 |
Why?
| Structure-Activity Relationship | 1 | 2001 | 533 | 0.010 |
Why?
| Complement Activation | 1 | 2002 | 350 | 0.010 |
Why?
| Protein Folding | 1 | 2001 | 255 | 0.010 |
Why?
| Cells, Cultured | 1 | 2006 | 4159 | 0.010 |
Why?
| Computer Simulation | 1 | 2001 | 953 | 0.010 |
Why?
| HIV-1 | 1 | 2001 | 787 | 0.010 |
Why?
| Mice | 2 | 2002 | 15984 | 0.010 |
Why?
| Mice, Knockout | 1 | 2001 | 2736 | 0.010 |
Why?
| Models, Biological | 1 | 2002 | 1753 | 0.010 |
Why?
| T-Lymphocytes | 1 | 2001 | 1793 | 0.010 |
Why?
|
|
Young's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|